Jeffrey I Everitt Selected Research

Inflammation (Inflammations)

3/2024	Irgm proteins attenuate inflammatory disease in mouse models of genital Chlamydia infection.
1/2023	Spontaneous episodic inflammation in the intestines of mice lacking HNF4A is driven by microbiota and associated with early life microbiota alterations.
12/2022	Mixed-surface polyamidoamine polymer variants retain nucleic acid-scavenger ability with reduced toxicity.
10/2022	Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.
11/2009	Inhaled carbon nanotubes reach the subpleural tissue in mice.
6/2004	Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
6/2004	Nasal toxicity of manganese sulfate and manganese phosphate in young male rats following subchronic (13-week) inhalation exposure.
7/2003	Soluble ICAM-1, MCP-1, and MIP-2 protein secretion by rat pleural mesothelial cells following exposure to amosite asbestos.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey I Everitt Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 04/2002
8	Inflammation (Inflammations) 03/2024 - 07/2003
5	Infections 03/2024 - 04/2003
4	Carcinogenesis 12/2022 - 03/2004
3	Wounds and Injuries (Trauma) 12/2022 - 01/2020
3	Necrosis 10/2021 - 08/2004
3	Fibrosis (Cirrhosis) 01/2011 - 11/2009
2	Cicatrix (Scar) 03/2024 - 11/2021
2	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2022
2	Hepatorenal form of glycogen storage disease 06/2023 - 11/2018
2	Hypoglycemia (Reactive Hypoglycemia) 06/2023 - 11/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2022
2	Human Influenza (Influenza) 12/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2021
2	Glycogen Storage Disease Type II (Pompe's Disease) 06/2020 - 01/2019
2	Leiomyoma (Uterine Fibroids) 04/2012 - 05/2007
2	Acute-Phase Reaction 10/2004 - 08/2002
2	Leukemia 10/2003 - 04/2003
2	Pneumonia (Pneumonitis) 07/2003 - 04/2003
2	Asthma (Bronchial Asthma) 04/2003 - 04/2003
2	Bronchitis 04/2003 - 04/2003
1	Chlamydia Infections 03/2024
1	Granuloma 03/2024
1	Prostatic Neoplasms (Prostate Cancer) 12/2023
1	Fatigue 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Colitis 01/2023
1	Hernia (Hernias) 01/2023
1	Stress Fractures (Stress Fracture) 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	COVID-19 10/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Contracture 11/2021
1	Osteosarcoma (Osteogenic Sarcoma) 11/2020
1	Urolithiasis 11/2018
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2017
1	Autoimmune Diseases (Autoimmune Disease) 12/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2003
4	PolymersIBA 01/2023 - 01/2021
4	CytokinesIBA 10/2022 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
3	ChemokinesIBA 10/2022 - 04/2003
3	CarcinogensIBA 07/2006 - 10/2003
3	Particulate MatterIBA 07/2003 - 04/2003
2	Aspartame (NutraSweet)IBA 09/2023 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Nucleic AcidsIBA 12/2022 - 01/2022
2	Protein Isoforms (Isoforms)IBA 12/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 10/2022 - 04/2003
2	Ethanol (Ethyl Alcohol)IBA 10/2021 - 01/2021
2	AcidsIBA 06/2020 - 01/2019
2	GlucosidasesIBA 06/2020 - 01/2019
2	Histone MethyltransferasesIBA 02/2017 - 04/2012
2	Histones (Histone)IBA 04/2012 - 08/2004
2	Benzene (Benzole)IBA 10/2003 - 04/2003
2	SootIBA 04/2003 - 04/2003
2	Tuberous Sclerosis Complex 2 ProteinIBA 02/2003 - 08/2002
1	GTP Phosphohydrolases (GTPases)IBA 03/2024
1	InterferonsIBA 03/2024
1	trichlorosucrose (sucralose)IBA 02/2024
1	ProdrugsIBA 12/2023
1	Glutamine (L-Glutamine)FDA Link 12/2023
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 06/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Hepatocyte Nuclear Factor 4IBA 01/2023
1	Elastomers (Elastomer)IBA 01/2023
1	POEGMAIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Polypropylenes (Polypropylene)IBA 01/2023
1	Cathepsin LIBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Cytidine Diphosphate (CDP)IBA 01/2022
1	CyclodextrinsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	dilactideIBA 11/2021
1	caprolactoneIBA 11/2021
1	CollagenIBA 11/2021
1	SolutionsIBA 10/2021
1	Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2020
1	poly(ester-urea)IBA 01/2020
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2019
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2019
1	CationsIBA 01/2019
1	Calcium OxalateIBA 11/2018
1	calcium phosphateIBA 11/2018
1	bisphenol AIBA 04/2012
1	Diethylstilbestrol (Stilbestrol)FDA Link 04/2012

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2007
1	Castration 12/2023
1	Injections 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 11/2021
1	Operative Surgical Procedures 01/2020